385 related articles for article (PubMed ID: 27154285)
1. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment.
Santos CMA; Pires MCV; Leão TL; Hernández ZP; Rodriguez ML; Martins AKS; Miranda LS; Martins FS; Nicoli JR
Microbiology (Reading); 2016 Jul; 162(7):1195-1207. PubMed ID: 27154285
[TBL] [Abstract][Full Text] [Related]
2. Interpretation of vaginal metagenomic characteristics in different types of vaginitis.
Song J; Dong X; Lan Y; Lu Y; Liu X; Kang X; Huang Z; Yue B; Liu Y; Ma W; Zhang L; Yan H; He M; Fan Z; Guo T
mSystems; 2024 Mar; 9(3):e0137723. PubMed ID: 38364107
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of two Lactobacillus strains during infection with Gardnerella vaginalis and Candida albicans in a HeLa cell culture model.
Santos CMA; Pires MCV; Leão TL; Silva AKS; Miranda LS; Martins FS; Silva AM; Nicoli JR
Microbiology (Reading); 2018 Mar; 164(3):349-358. PubMed ID: 29458690
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
Vicariotto F; Del Piano M; Mogna L; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
6. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
[TBL] [Abstract][Full Text] [Related]
7. Exploring of probiotic potential vaginal lactobacillus isolates from healthy women against Gardnerella vaginalis and Caenorhabditis elegans model testing.
Li Y; Jiang Y; Lessing DJ; Chu W
J Appl Microbiol; 2022 Sep; 133(3):1392-1401. PubMed ID: 35633296
[TBL] [Abstract][Full Text] [Related]
8. Probiotics for the treatment of women with bacterial vaginosis.
Falagas M; Betsi GI; Athanasiou S
Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390
[TBL] [Abstract][Full Text] [Related]
9. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida.
Strus M; Kucharska A; Kukla G; Brzychczy-Włoch M; Maresz K; Heczko PB
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):69-75. PubMed ID: 16011996
[TBL] [Abstract][Full Text] [Related]
10. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
van de Wijgert J; Verwijs MC
BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
[TBL] [Abstract][Full Text] [Related]
11. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota?
Pramanick R; Mayadeo N; Warke H; Begum S; Aich P; Aranha C
Microb Pathog; 2019 Sep; 134():103599. PubMed ID: 31212037
[TBL] [Abstract][Full Text] [Related]
12. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets.
Mastromarino P; Brigidi P; Macchia S; Maggi L; Pirovano F; Trinchieri V; Conte U; Matteuzzi D
J Appl Microbiol; 2002; 93(5):884-93. PubMed ID: 12392537
[TBL] [Abstract][Full Text] [Related]
13. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
Happel AU; Kullin B; Gamieldien H; Wentzel N; Zauchenberger CZ; Jaspan HB; Dabee S; Barnabas SL; Jaumdally SZ; Dietrich J; Gray G; Bekker LG; Froissart R; Passmore JS
PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109
[TBL] [Abstract][Full Text] [Related]
14. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.
Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B
PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675
[TBL] [Abstract][Full Text] [Related]
15. Probiotics in vaginal health.
Mashatan N; Heidari R; Altafi M; Amini A; Ommati MM; Hashemzaei M
Pathog Dis; 2023 Jan; 81():. PubMed ID: 37286796
[TBL] [Abstract][Full Text] [Related]
16. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis.
McLEAN NW; Rosenstein IJ
J Med Microbiol; 2000 Jun; 49(6):543-552. PubMed ID: 10847208
[TBL] [Abstract][Full Text] [Related]
17. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
[TBL] [Abstract][Full Text] [Related]
19. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of vaginal
Takano T; Kudo H; Eguchi S; Matsumoto A; Oka K; Yamasaki Y; Takahashi M; Koshikawa T; Takemura H; Yamagishi Y; Mikamo H; Kunishima H
Front Cell Infect Microbiol; 2023; 13():1113401. PubMed ID: 37201113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
